{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:06:35Z","timestamp":1773889595874,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":280,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020218","name":"Chiesi USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Pharmaceuticals SpA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gimopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine Open"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.gimo.2025.103465","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T20:01:32Z","timestamp":1760558492000},"page":"103465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Delayed diagnosis and clinical course of alpha-mannosidosis: A retrospective study of 25 patients with varying severity"],"prefix":"10.1016","volume":"3","author":[{"given":"James H.","family":"Nurse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia B.","family":"Hennermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Curiati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nato","family":"Vashakmadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Donoghue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carmo","family":"Mac\u00e1rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilica","family":"Plaiasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal","family":"Tunde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-6332","authenticated-orcid":false,"given":"Karolina M.","family":"Stepien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108444","article-title":"Diagnosis of alpha-mannosidosis: practical approaches to reducing diagnostic delays in this ultra-rare disease","volume":"142","author":"Santoro","year":"2024","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.gimo.2025.103465_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-3-21","article-title":"Alpha-mannosidosis","volume":"3","author":"Malm","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.gimo.2025.103465_bib4","series-title":"GeneReviews\u00ae","article-title":"Alpha-mannosidosis","author":"Ficicioglu","year":"2024"},{"issue":"8","key":"10.1016\/j.gimo.2025.103465_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tins.2011.05.006","article-title":"Clarifying lysosomal storage diseases","volume":"34","author":"Schultz","year":"2011","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.gimo.2025.103465_bib6","article-title":"Disease progression of alpha-mannosidosis and impact on patients and carers\u2014a UK natural history survey","volume":"20","author":"Adam","year":"2019","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"10.1016\/j.gimo.2025.103465_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.20517\/jtgg.2023.58","article-title":"Molecular basis of neurocognitive dysfunction and psychosis in alpha-mannosidosis","volume":"8","author":"Dewsbury","year":"2024","journal-title":"J Transl Genet Genom"},{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10545-013-9622-2","article-title":"The natural course and complications of alpha-mannosidosis\u2014a retrospective and descriptive study","volume":"37","author":"Malm","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13023-022-02422-6","article-title":"Mortality in patients with alpha-mannosidosis: a review of patients\u2019 data and the literature","volume":"17","author":"Hennermann","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCD.0000000000000474","article-title":"Long-term outcome of a cohort of Italian patients affected with alpha-mannosidosis","volume":"33","author":"Bertolini","year":"2024","journal-title":"Clin Dysmorphol"},{"issue":"5","key":"10.1016\/j.gimo.2025.103465_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jimd.12138","article-title":"Ultra-orphan lysosomal storage diseases: a cross-sectional quantitative analysis of the natural history of alpha-mannosidosis","volume":"42","author":"Zielonka","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.gimo.2025.103465_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2024.104927","article-title":"Long-term clinical evaluation of patients with alpha-mannosidosis\u2014a multicenter study","volume":"68","author":"K\u00f6se","year":"2024","journal-title":"Eur J Med Genet"},{"issue":"suppl 1","key":"10.1016\/j.gimo.2025.103465_bib13","first-page":"S43","article-title":"Early clinical signs in lysosomal diseases","volume":"94","author":"Alkhzouz","year":"2021","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.gimo.2025.103465_bib14","article-title":"Long-term outcome of patients with alpha-mannosidosis\u2014a single center study","volume":"30","author":"Lipi\u0144ski","year":"2022","journal-title":"Mol Genet Metab Rep"},{"issue":"11","key":"10.1016\/j.gimo.2025.103465_bib15","doi-asserted-by":"crossref","first-page":"608","DOI":"10.12998\/wjcc.v2.i11.608","article-title":"Important of case-reports\/series, in rare diseases: using neuroendocrine tumors as an example","volume":"2","author":"Nakamura","year":"2014","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.gimo.2025.103465_bib16","series-title":"LAMZEDE (Velmanase alfa) Summary of Product Characteristics: Chiesi Farmaceutici","article-title":"LAMZEDE (velmanase alfa) Summary of Product Characteristics","year":"2022"},{"key":"10.1016\/j.gimo.2025.103465_bib17","series-title":"LAMZEDE (Velmanase alfa) Prescription Information: Chiesi Farmaceutici","article-title":"LAMZEDE (velmanase alfa) Prescription Information","year":"2023"},{"issue":"4","key":"10.1016\/j.gimo.2025.103465_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jimd.12602","article-title":"Long-term safety and efficacy of velmanase alfa treatment in children under 6 years of age with alpha-mannosidosis: a phase 2, open label, multicenter study","volume":"46","author":"Guffon","year":"2023","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12799","article-title":"Extended long-term efficacy and safety of velmanase alfa treatment up to 12 years in patients with alpha-mannosidosis","volume":"48","author":"Guffon","year":"2025","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.gimo.2025.103465_bib20","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10545-018-0175-2","article-title":"Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis","volume":"41","author":"Lund","year":"2018","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.gimo.2025.103465_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2018.04.003","article-title":"Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): novel global treatment response model and outcomes in patients with alpha-mannosidosis","volume":"124","author":"Harmatz","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib22","first-page":"15","article-title":"Early biochemical effects of velmanase alfa in a 7-month-old infant with alpha-mannosidosis","volume":"55","author":"Santoro","year":"2020","journal-title":"JIMD Rep"},{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13023-020-01549-8","article-title":"The SPARKLE registry: protocol for an international prospective cohort study in patients with alpha-mannosidosis","volume":"15","author":"Hennermann","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.gimo.2025.103465_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.gimo.2025.103465_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-015-0286-x","article-title":"Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation","volume":"10","author":"Borgwardt","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.gimo.2025.103465_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1750-1172-8-88","article-title":"Natural history of alpha mannosidosis a longitudinal study","volume":"8","author":"Beck","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.gimo.2025.103465_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/humu.22005","article-title":"Identification of 83 novel alpha-mannosidosis-associated sequence variants: functional analysis of MAN2B1 missense mutations","volume":"33","author":"Riise Stensland","year":"2012","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.gimo.2025.103465_bib28","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41431-024-01604-z","article-title":"Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey","volume":"32","author":"Faye","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.gimo.2025.103465_bib29","series-title":"Barriers to Rare Disease Diagnosis, Care and Treatment in the US: A 30-Year Comparative Analysis","year":"2020"},{"key":"10.1016\/j.gimo.2025.103465_bib30","series-title":"Rare Disease Drug Development: Clinical, Scientific, Patient, and Caregiver Perspectives","first-page":"233","article-title":"Rare diseases in the pediatric population","author":"Munta\u00f1ola","year":"2021"},{"issue":"20","key":"10.1016\/j.gimo.2025.103465_bib31","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMoa2035790","article-title":"100,000 genomes pilot on rare-disease diagnosis in health care\u2014preliminary report","volume":"385","author":"Smedley","year":"2021","journal-title":"N Engl J Med"},{"issue":"8003","key":"10.1016\/j.gimo.2025.103465_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the All of US Research Program","volume":"627","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.gimo.2025.103465_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108519","article-title":"Monitoring and integrated care coordination of patients with alpha-mannosidosis: a global Delphi consensus study","volume":"142","author":"Guffon","year":"2024","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.gimo.2025.103465_bib35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ymgme.2019.01.024","article-title":"Recognition of alpha-mannosidosis in paediatric and adult patients: presentation of a diagnostic algorithm from an international working group","volume":"126","author":"Guffon","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.gimo.2025.103465_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.12231","article-title":"Perspectives of rare disease experts on newborn genome sequencing","volume":"6","author":"Gold","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.gimo.2025.103465_bib37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/ddae201","article-title":"Choroid plexus-targeted viral gene therapy for alpha-mannosidosis, a prototypical neurometabolic lysosomal storage disease","volume":"34","author":"Choi","year":"2025","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0883073812470973","article-title":"Alpha-mannosidosis: a report of 2 siblings and review of the literature","volume":"29","author":"Govender","year":"2014","journal-title":"J Child Neurol"},{"issue":"6","key":"10.1016\/j.gimo.2025.103465_bib39","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10545-018-0185-0","article-title":"Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial","volume":"41","author":"Borgwardt","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.gimo.2025.103465_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2326409818796854","article-title":"Health related quality of life, disability, and pain in alpha mannosidosis: long-term data of enzyme replacement therapy with velmanase alfa (human recombinant alpha mannosidase)","volume":"6","author":"Borgwardt","year":"2018","journal-title":"J Inborn Errors Metab Screen"},{"issue":"2","key":"10.1016\/j.gimo.2025.103465_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107866","article-title":"Long-term efficacy of velmanase alfa treatment in patients with alpha-mannosidosis: pooled data from two extension studies (up to 12 years of therapy)","volume":"141","author":"Guffon","year":"2024","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13023-025-03694-4","article-title":"Evolution of mobility, pain\/discomfort, self-care, and mental health in patients with alpha-mannosidosis: an international caregiver and patient survey","volume":"20","author":"Stepien","year":"2025","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gimo.2025.103465_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12325-020-01574-w","article-title":"Caregivers\u2019 and physicians\u2019 perspectives on alpha-mannosidosis: a report from Italy","volume":"38","author":"Verrecchia","year":"2021","journal-title":"Adv Ther"}],"container-title":["Genetics in Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774425015043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774425015043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:22:35Z","timestamp":1773876155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949774425015043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"alternative-id":["S2949774425015043"],"URL":"https:\/\/doi.org\/10.1016\/j.gimo.2025.103465","relation":{},"ISSN":["2949-7744"],"issn-type":[{"value":"2949-7744","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed diagnosis and clinical course of alpha-mannosidosis: A retrospective study of 25 patients with varying severity","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gimo.2025.103465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"103465"}}